Recently, in addition to EGFR and ALK, researchers have discovered an increasing number of driver genes in NSCLC, but these genes typically have a mutation rate of <5 % in NSCLC and are referred to as uncommon mutations. The gene discussed is ALK; the disease is non-small cell lung carcinoma.